Skip to main contentPsst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveFree Webinar — Wednesday, October 28 at 2:00 PM ET

Register Free →

Clinical Graft Monitoring Tool Prototyping

Active
Grant

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

This subcontract opportunity with the Department of the Army USAMRRA involves the development of assays, devices, and technology for clinical graft monitoring in support of Defense Health Agency research projects. The selected provider will prototype monitoring devices and integrate biomarkers into tools specifically designed for the human use factors associated with vascularized composite allotransplantation recipients. The project requires the delivery of a functional prototype or a validated assay kit. To qualify, providers must possess bio-engineering facilities and adhere to ISO 13485 or FDA Quality System Regulation standards. The work falls under NAICS code 541715 and is focused on advancing clinical monitoring capabilities for the Department of Defense.

General Info

Army subcontract for developing clinical graft monitoring assays and devices for DHA research.

Documents

This scope was carved out of HT942526RTRPCA.

The full solicitation package (2 documents), including the RFP, is on the prime solicitation, not on this scope.

View the prime solicitation

DoW Reconstructive Transplant, Concept Award

AI Contract Breakdown

Uniform Contract Format

No documents to break down

The breakdown needs solicitation documents. None were found from this contract's source.

Timeline

Posted

subcontract

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more
AgencyDepartment Of Defense → Department Of The Army -- Usamraa
ContactsNo contacts available
OfficeN/A
Office AddressN/A
ContactsNo contact information available

Full Description

Show more
Develops assays, devices, or technology for clinical graft monitoring for prime contractors on Defense Health Agency (DHACA) research projects. Prototypes monitoring devices and integrates biomarkers into tools designed for human use factors unique to VCA recipients. Requires ISO 13485 or FDA QSR standards and bio-engineering facilities. Delivers a functional prototype or validated assay kit.

Similar Contracts

Same NAICS industry code

NAICS: 541715
New
Federal
ACC-DTA Commercial Solutions Opening (CSO)
Solicitation # W912CH-26-S-0001
The Army Contracting Command – Detroit Arsenal (ACC-DTA) Commercial Solutions Opening (CSO), solicitation W912CH-26-S-0001, serves as a rapid-acquisition gateway to transition cutting-edge commercial technologies into active defense programs. This vehicle supports a diverse customer base, including the Intelligence and Security Command (INSCOM) and six Portfolio Acquisition Executives, focusing on the development, integration, and sustainment of ground vehicle systems to enhance Army modernization and readiness. The CSO utilizes a streamlined, merit-based, multi-phased evaluation process consisting of solution briefs, presentations, and commercial solution proposals. Awards may be issued through 2028 as FAR Part 12 contracts or non-FAR agreements, such as Other Transaction Authority (OTA) and Cooperative Agreements. The solicitation is organized around various Areas of Interest (AoI) that address critical military needs. Key initiatives include the FALCONS prototype effort for long-range reconnaissance sensors with funding ceilings between 24 million and 30 million dollars, the TIGER Readiness and Hackathon programs for Abrams Main Battle Tank engine supply chain resilience, and requirements for Counter-Unmanned Aircraft Systems (C-UAS) detection, Mobile Camouflage Systems, and Light Tactical Trailer Heavy Chassis. Technical evaluations focus on mission viability and prototype execution, while price proposals are assessed for affordability. To be eligible for award, companies must be registered in the System for Award Management (SAM) with a Unique Entity ID and comply with the Buy American Act and Specialty Metals clauses.
W6QK Acc- Dta

POSTED

about 10 hours ago

DEADLINE

in about 2 years
View Details
NAICS: 541715
New
Federal
BAA DEVCOM AC Emerging Technologies
Solicitation # W15QKN-26-S-1AZR
The U.S. Army Combat Capabilities Development Command Armaments Center is soliciting research proposals and white papers for new and innovative technologies related to emerging weapons, munitions systems, and soldier lethality. Issued under FAR 6.102(d)(2), this Broad Agency Announcement is a continuously open solicitation effective from March 5, 2026, through March 4, 2031. The program seeks to advance the state of the art through collaborations with industry and academia, with a particular interest in scientific study and experimentation that fills technology needs across the product life cycle, including improvements in armament packaging, ammunition logistics, and micro-system architecture. The submission process is a two-stage effort beginning with a white paper, which is limited to six pages plus a cover page and biographical sketches. Offerors whose white papers are favorably evaluated may be invited to submit a full research proposal. The government prefers proposals covering a three-year period of performance with incremental funding. Awards are based on a competitive selection process evaluating overall scientific and technical merit, potential contributions to the Army mission, offeror capabilities, personnel qualifications, past performance, and proposed price. All submissions must be unclassified and adhere to strict formatting guidelines, including 12-point Times New Roman font for narrative text.
W6QK Acc-Ri-Picatinny

POSTED

about 10 hours ago

DEADLINE

in over 4 years
View Details
NAICS: 541715
New
Federal
Common Autonomous Multi-Domain Launcher (CAML)-Lite Prototype Effort
Solicitation # W50RAJ27CAML_LITE
The Common Autonomous Multi-Domain Launcher (CAML)-Lite Prototype Effort is a competitive procurement conducted under 10 U.S.C. section 4022 for the development of a mobile, optionally manned, autonomous launcher designed to increase survivability and reduce manned support for cross-domain fires. Managed by the Department of Defense, this effort utilizes Other Transaction Agreements (OTAs) and follows a two-phase structure. Phase 1 focuses on a government-sponsored prototype demonstration at Talisman Sabre 2027 in August 2027, with options for the government to acquire additional prototype units, new equipment training, and contractor logistics support. Phase 2 involves maturing selected solutions into a production-representative configuration integrated into a common CAML architecture. The procurement process begins with a Request for Solutions Brief to identify meritorious respondents, who will then be invited to submit a Request for Prototype Proposal. Key technical requirements include the use of a Modular Open Systems Approach (MOSA) to ensure interchangeable modules and common interfaces. Performers are required to assume full responsibility for international logistics and compliance for the Phase 1 demonstration and must adhere to minimum Right to Repair requirements as a condition of award. Selection for Phase 1 is based on the feasibility of the maturation path and the technical soundness of the approach, while subsequent option exercises will prioritize speed of delivery, technical performance, property rights, and the right to repair. Phase 1 OTA awards are expected by December 18, 2026, with a firm-fixed-price payment structure split between award and demonstration completion.
W6DV Peo M & S Redstone

POSTED

1 day ago

DEADLINE

in about 23 hours
View Details
NAICS: 541715
New
Federal
Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and SupplieS (FASTPASS) Innovative Solutions Opening
Solicitation # ARPA-H-SOL-26-160
The Fast Assessment of Solutions, Therapeutics, Pharmaceuticals, and Supplies (FASTPASS) program, under solicitation ARPA-H-SOL-26-160, is an initiative by the Advanced Research Projects Agency for Health (ARPA-H) to develop a near real-time, non-destructive, AI-enabled screening system. The goal is to identify contamination, adulteration, and quality defects in pharmaceutical products through their packaging at ports of entry and other supply-chain nodes using multi-modal sensing and data fusion. This 54-month program is structured into three 18-month phases, culminating in a fieldable platform with validated training materials and integrated documentation capabilities. This procurement is conducted as a multiple-award Other Transaction (OT) Agreement rather than a standard federal contract, meaning it is governed by specific OT articles instead of the Federal Acquisition Regulation. Awards are based on the most advantageous proposals, with primary evaluation factors including innovation, soundness, execution planning, risk management, and team expertise. Payments are fixed and triggered by the successful completion of milestones, managed through the Payment Management System. Proposers must be registered in SAM.gov and provide detailed technical and cost proposals, including a milestone payment schedule and research security disclosures. Amendment 01 specifically updated the cost proposal narrative model and workbook to correct typographical errors and rename appendices.
Advanced Research Projects Agency For Health (arpa-H)

POSTED

1 day ago

DEADLINE

in 19 days
View Details

More opportunities from Department Of Defense → Department Of The Army -- Usamraa

Same awarding agency

NAICS: 518210
Grant
Data Management and Research Sharing Plan DevelopmentThe contract seeks the design and implementation of a secure, compliant data management plan tailored for biomedical research, with a strong emphasis on preserving data integrity, adhering to FAIR principles—findable, accessible, interoperable, and reusable—and meeting federal requirements for data sharing. The plan must ensure that all research data is handled in a manner that supports long-term preservation, ethical use, and regulatory compliance, particularly under Department of Defense standards. The subcontractor will be responsible for developing structured policies and technical workflows that align with evolving federal mandates, enabling seamless data sharing while maintaining rigorous security protocols to protect sensitive biomedical information. The initiative is managed by the Department of the Army through USAMRAA under the broader Department of Defense, with the NAICS code 518210 indicating its focus on data processing and hosting services. The opportunity is open as a subcontract, with responses due by November 4, 2026. While the physical place of performance and point of contact are not specified, the work must be executed to meet federal compliance timelines and deliverables without reliance on proprietary or non-standard frameworks. The goal is to establish a scalable, audit-ready data infrastructure that supports ongoing and future biomedical research initiatives under federal oversight.
Computing Infrastructure Providers, Data Processing, Web Hosting, and Related Services

POSTED

4 months ago

DEADLINE

in 12 days
View Details
NAICS: 541715
Grant
DoW Reconstructive Transplant, Concept Award
Solicitation # HT942526RTRPCA
The Defense Health Agency Contracting Activity is soliciting applications for the fiscal year 2026 Reconstructive Transplant Research Program Concept Award under solicitation HT942526RTRPCA. This program supports the exploration of highly innovative new concepts or untested theories that address critical problems in reconstructive transplantation, specifically those aligned with FY26 RTRP Focus Areas. The award is designed for high-risk, high-reward research that introduces new paradigms or creative perspectives, and it explicitly excludes clinical trials and incremental advances based on existing data. Early-career investigators at or above the postdoctoral fellow level are encouraged to apply. Funding is capped at 200,000 dollars per award for a maximum period of performance of 18 months, with an overall program appropriation of 12 million dollars. The selection process involves a two-tier review consisting of a peer review for technical merit followed by a programmatic review for relevance to military health and program priorities. Applicants must maintain active registrations in SAM.gov, eBRAP.org, and Grants.gov. Key submission requirements include a three-page Statement of Work, a one-page Innovation Statement, and a one-page Post-Award Transition Plan. All applications must be submitted by the specified deadlines, with full applications from extramural organizations required to go through the Grants.gov Workspace. Special attention is required for the disclosure of foreign affiliations of key personnel and the approval of the DHA R&D Office of Research and Regulatory Compliance for any research involving human or animal subjects.
Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)

POSTED

5 months ago

DEADLINE

in 12 days
View Details

Ready to Pursue This Opportunity?

Get AI-powered intelligence on this solicitation and the ones like it

Every page of the solicitation package shredded into a compliance breakdown

AI-powered matching based on your capabilities and past performance

Competitor and incumbent history on the requirement

Automated alerts on amendments, Q&A deadlines, and award

Miguel
Hillary
Keith Deutsch
Christine

Join 750+ contractors already using CLEATUS